Each gram of product contains Tiamulin hydrogen fumarate 800 mg
Pigs and broilers
Pigs - For the treatment of anaerobic dysentery, swine enzootic pneumonia, mycoplasma infections, secondary infections, caused by germs susceptible to tiamulin hydrogen fumarate.
Broilers - For the treatment of chronic respiratory disease, mycoplasmosis and infectious arthritis produced by germs susceptible to tiamulin hydrogen fumarate.
Do not administer to herbivores. Do not use in animals with known hypersensitivity to the active substance or to the excipient.
Occasionally, hypersensitivity reactions to tiamulin may occur, manifested as erythema.
The treatment consists of oral administration of TIAGEN 80%, individually or in mass (by incorporation in fodder), for 3-7 consecutive days at different doses, depending on species, age, body weight, physiological status and state of health. To ensure a correct dose, the body weight of the animals should be accurately determined, whenever possible, to avoid underdosing. For mass treatment, the animals should be grouped according to body weight and should be dosed appropriately to avoid under- or overdosing. To ensure good homogenisation of the product, it must first be mixed with a suitable amount of fodder to obtain a premix before it is incorporated into the final fodder.
Pigs - Administer a dose of 8-10 mg active substance/kg body weight/day, equivalent to 10-12.5 mg of Tiagen 80%/kg of body weight/day.
Broilers - Administer a dose of 15-20 mg active substance/kg body weight/day, equivalent to 19-25 mg of Tiagen 80%/kg of body weight/day. Throughout treatment, animals should consume only medicated fodder.
Fodder consumption should be monitored to ensure adequate dose. If the fodder consumption does not correspond to the quantities for which the recommended concentrations have been calculated, the TIAGEN 80% concentration should be adjusted so that the animals assimilate the recommended dose. Otherwise another medication should be considered.
Pigs Meat and offal: 6 days
Broilers Meat and offal: 4 days
Do not use the product in poultry whose eggs are intended for human consumption.
Keep out of reach of children. Do not store above 25°C. Keep in the original package. Store in a dry place. Keep away from direct light. Do not use after the expiry date printed on the label.
Shelf life of the veterinary medicinal product as packaged for sale: 2 years. Shelf-life after first opening the immediate packaging: 28 days. Shelf-life after incorporation into fodder: 28 days.
The ingestion of medicated fodder by the animal may be affected by the disease.
If animals do not ingest enough fodder to provide their medication, the treatment schedule will be reviewed and the animals treated adequately parenterally.
The use of the product should be based on the results of susceptibility testing of isolated bacteria. If this is not possible, therapy will be based on epidemiological information on the susceptibility of isolated bacteria.
Using the product in violation of the instructions in the SmPC may increase the prevalence of tiamulin resistance and may decrease the effectiveness of antimicrobial treatments in the pleuromutilin group as a result of cross-resistance.
Those with known hypersensitivity to any of the product components should avoid any contact with the product. The product may cause irritation of the respiratory tract and eyes in case of inhalation or contact. If irritation persists, consult a physician and show the package leaflet or product label. Appropriate protection measures should be taken during product incorporation into fodder. Specialised personnel must wear goggles and masks. In case of contact with eyes, rinse with plenty of water. Do not eat, drink or smoke during product handling. Wash hands after use.
Studies in laboratory animals have revealed no embryotoxic or teratogenic potential. Product safety has not been demonstrated during the gestation and lactation period. Product can be administered during gestation and lactation after the risk-benefit ratio has been assessed by a veterinarian.
Do not administer in combination with monensin, narasin, salinomycin.
Do not exceed the recommended dose. In case of overdose, salivation or vomiting may occur.
In the absence of compatibility studies, this veterinary medicinal product shall not be mixed with other veterinary medicinal products.
Any unused veterinary medicinal product or waste materials derived from such products should be disposed of in accordance with local requirements.
The treated animals will be kept in shelters throughout the treatment and the manure from them will be collected and SHALL NOT be used for soil fertilisation. Medicines should not be disposed of via waste water or household waste.
100g, 1 kg, 5 kg laminated terephthalate polyethylene foil/low-density polyethylene bags.
10kg, 25kg, 50kg laminated terephthalate polyethylene foil/aluminium/low-density polyethylene bags sealed by heat-sealing.